echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Amino Acids Research > The general manager of Meihua Bio is under investigation for bribery

    The general manager of Meihua Bio is under investigation for bribery

    • Last Update: 2020-06-28
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    yesterday evening, Meihua Biological (quote 600873, consultation unit) issued a notice that, july 23, Baotou City People's Procuratorate through its WeChat public number "Baotou Prosecution" issued a message, "Recently, Baotou City Rare Earth High-tech District People's Procuratorate in accordance with the law on Tongliao Meihua Biotech Co., Ltdand its former general manager He Jun suspected of bribery investigation, the investigation of the case is under way."WfY
    Meihua Bio said that He Jun is now the company's director, general manager, currently normal performance, not affected by the investigation, the company and subsidiaries of normal production and operationThe company will closely monitor the follow-up progress, in strict accordance with regulatory requirements to meet the obligation to disclose informationWfY
    According to the public information of Meihua Bio, Tongliao Meihua Biotech Co., Ltdis a wholly owned subsidiary of the company, and according to the company's annual report last year, on January 16, 2017, the company held the first interim shareholders' meeting of 2017, at which Wang Aijun, He Jun, Liang Yubo, Luo Qinghua and Guo Chunming were elected as directors of the 8th Board of DirectorsWfY
    The "trouble" of Meihua bio is not limited to this, as early as May 25 this year, the company announced that shareholder Meng Qingshan received the Notice of Investigation of the China Securities Regulatory Commission, suspected of illegal violations, in accordance with the relevant provisions of the Securities Law of the People's Republic of China, the CSRC decided to open a case against itWfY
    Meng Qingshan's holdings of the company account for 27.48% of the company's total share capitalAt that time, the announcement said that Meng Qingshan is not currently in any position in the company, the investigation is only for its individual, and the company has nothing to do with the company, the company and its subsidiaries production and operation is normalHowever, the inquiry announcement can be seen, Meng Qingshan in January this year only from The Plum Bio to step down as chairmanWfY
    However, Meng Qingshan, Wang Aijun, He Jun as the concerted action person, is the actual controller of the listed companyIn April 2017, China Integrity Securities Assessment Co., Ltd(hereinafter referred to as The China Integrity Certificate) tracked the bond issued by the companyHowever, in response to the Csrc launched a case investigation into Meng Qingshan, the company has issued a notice that the China Integrity Certificate will maintain close contact with Meihua Bio, and continue to pay close attention to the progress of the matter and the impact on the company's future development strategy, business operations and credit statusWfY
    On July 25, Meihua Bio announced that the Company's 2015 Corporate Bonds (Phase 1) will begin paying interest for the period from July 31, 2016 to July 30, 2017 (in the event of a public holiday or rest date extended to the first working day thereafter)WfY yesterday evening, Meihua Biological (quote 600873, consultation unit) issued a notice that july 23, Baotou City People's Procuratorate through its Micro-Credit public number "Baotou Prosecution" issued a message, "Recently, Baotou City Rare Earth High-tech District People's Procuratorate in accordance with the law on Tongliao Meihua Biotech Co., Ltdand its former general manager He Jun suspected of bribery crime investigation, the investigation of the case is under way."WfY
    Meihua Bio said that He Jun is now the company's director, general manager, currently normal performance, not affected by the investigation, the company and subsidiaries of normal production and operationThe company will closely monitor the follow-up progress, in strict accordance with regulatory requirements to meet the obligation to disclose information WfY
      According to the public information of Meihua Bio, Tongliao Meihua Biotech Co., Ltd is a wholly owned subsidiary of the company, and according to the company's annual report last year, on January 16, 2017, the company held the first interim shareholders' meeting of 2017, at which Wang Aijun, He Jun, Liang Yubo, Luo Qinghua and Guo Chunming were elected as directors of the 8th Board of Directors WfY
      The "trouble" of Meihua bio is not limited to this, as early as May 25 this year, the company announced that shareholder Meng Qingshan received the Notice of Investigation of the China Securities Regulatory Commission, suspected of illegal violations, in accordance with the relevant provisions of the Securities Law of the People's Republic of China, the CSRC decided to open a case against it WfY
      Meng Qingshan's holdings of the company account for 27.48% of the company's total share capital At that time, the announcement said that Meng Qingshan is not currently in any position in the company, the investigation is only for its individual, and the company has nothing to do with the company, the company and its subsidiaries production and operation is normal However, the inquiry announcement can be seen, Meng Qingshan in January this year only from The Plum Bio to step down as chairman WfY
      However, Meng Qingshan, Wang Aijun, He Jun as the concerted action person, is the actual controller of the listed company In April 2017, China Integrity Securities Assessment Co., Ltd (hereinafter referred to as The China Integrity Certificate) tracked the bond issued by the company However, in response to the Csrc launched a case investigation into Meng Qingshan, the company has issued a notice that the China Integrity Certificate will maintain close contact with Meihua Bio, and continue to pay close attention to the progress of the matter and the impact on the company's future development strategy, business operations and credit status WfY
      On July 25, Meihua Bio announced that the Company's 2015 Corporate Bonds (Phase 1) will begin paying interest for the period from July 31, 2016 to July 30, 2017 (in the event of a public holiday or rest date extended to the first working day thereafter) WfY
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.